Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BRIVARACETAM vs BROLUCIZUMAB-DBLL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BRIVARACETAM vs BROLUCIZUMAB-DBLL: Safety Overview

Metric BRIVARACETAM BROLUCIZUMAB-DBLL
Total FAERS Reports 6,098 2,802
Deaths Reported 317 198
Death Rate 5.2% 7.1%
Hospitalizations 1,536 170
Average Patient Age 40.6 yrs 76.6 yrs
% Female Patients 54.4% 57.3%
FDA Approval Date Dec 20, 2022 N/A
Manufacturer Aurobindo Pharma Limited N/A
Route ORAL N/A
Marketing Status Prescription Prescription